From August 21 to 23, 2019, the 5th International Pharmaceutical Raw Materials Korea Exhibition CPhI Korea was held in Seoul, South Korea. Hangzhou Tianqu Biotechnology Co., Ltd. (referred to as Tianqu Biotechnology) participated in the exhibition.
During the three days of the exhibition, Tianqu Biological's booth attracted many exhibitors. Hundreds of product catalogs and brochures were requested by interested customers. Our company's staff have always communicated with exhibitors with full enthusiasm and serious attitude.
CPhI Korea, the International Pharmaceutical Raw Materials Exhibition in Korea, is a world-famous pharmaceutical professional exhibition, attracting major pharmaceutical companies from around the world to participate in the exhibition every year. The net area of this exhibition has been expanded four times compared to the first one. The exhibition gathered more than 260 overseas independent exhibitors from South Korea, India, Poland, Turkey, France, Italy and other countries, and attracted 5,000 people from different countries and regions at home and abroad to conduct market development, information collection, and brand promotion. and sales, etc.
The Korean pharmaceutical market is one of the most developed pharmaceutical markets in Asia. Its pharmaceutical business investment environment is second only to Japan and ranks second in Asia. According to the forecast of BMI, a British international business testing agency, South Korea's drug imports are expected to rise from US$3.2 billion in 2008 to US$6.4 billion in 2013. Its people's demand for drugs to treat chronic diseases and the government's large-scale investment in drug research and development , will also greatly increase the country's market demand for APIs, and will be a huge opportunity for Chinese pharmaceutical companies that mainly produce and export APIs and generic drugs.
